Constellation Brands
STZ
$0.00
-0.88%
Constellation Brands, Inc. is a leading alcoholic beverage company in the United States, primarily operating in the beer, wine, and spirits categories. The company is the dominant market leader in high-end Mexican beer imports in the US, with its portfolio anchored by powerhouse brands like Modelo Especial and Corona Extra, which drive over 90% of its revenue. The current investor narrative is heavily focused on the company's ability to sustain growth and margins for its core beer business amidst a competitive landscape, while also navigating its strategic investments, such as its stake in Canopy Growth, and managing the ongoing pruning of its non-core wine and spirits assets, as evidenced by recent market reactions to earnings guidance.…
STZ
Constellation Brands
$0.00
Related headlines
STZ 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Constellation Brands's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
7 analysts
Implied Upside
—
vs. current price
Analyst Count
7
covering this stock
Price Range
$0 - $0
Analyst target range
Coverage of STZ is limited in the provided dataset, with only 7 analysts contributing to estimates, suggesting institutional interest is present but not overwhelming. The consensus appears mixed, as evidenced by recent institutional rating actions including a 'Buy' initiation from Citigroup and reiterated 'Buy' or 'Outperform' ratings from Needham, UBS, and Bernstein, balanced by 'Hold' or 'Equal Weight' stances from Deutsche Bank and Barclays. The average target price data is not explicitly provided, so the implied upside or downside cannot be calculated; however, the recent news of the stock 'fizzling' after Q4 earnings due to disappointing guidance indicates near-term analyst sentiment may be tempered despite the long-term bullish case for its beer portfolio. The range of analyst estimates shows significant dispersion, with FY2026 EPS estimates spanning from $15.21 to $16.14, and revenue estimates from $9.86 billion to $10.32 billion; this wide range reflects uncertainty around the company's near-term growth and margin trajectory, particularly in the context of potential industry headwinds and the performance of its non-beer assets.
Bulls vs Bears: STZ Investment Factors
The evidence currently tilts bearish, driven by recent fundamental deterioration and severe technical underperformance. The core bull thesis rests on the company's strong cash generation, healthy margins, and dominant beer portfolio, which are durable strengths. However, the bear case is reinforced by a clear revenue slowdown, a guidance miss that shook investor confidence, and a stock in a pronounced downtrend. The single most important tension in the investment debate is whether the recent revenue decline is a temporary setback for the powerhouse beer brands or the beginning of a sustained slowdown in its core growth engine. The resolution of this tension, visible in upcoming quarterly sales figures, will dictate the stock's direction.
Bullish
- Strong Free Cash Flow & Dividend: The company generates robust free cash flow of $1.76 billion TTM, providing ample capacity for its 2.58% dividend yield, share buybacks, and debt service. This financial strength offers a margin of safety and supports shareholder returns.
- Healthy Profitability Margins: Constellation maintains impressive gross and operating margins of 51.55% and 31.33% respectively, which are healthy for the beverage industry. These margins underpin solid profitability, with a trailing net margin of 18.5%.
- Attractive Forward Valuation: The stock trades at a forward P/E of 12.0x, a 27% discount to its trailing P/E of 16.4x, indicating the market expects a significant earnings recovery. This valuation is in line with large-cap beverage peers and does not command a premium.
- Dominant Market Position in Beer: The company's beer segment, driven by Modelo and Corona, generates over 90% of revenue, providing a stable and dominant cash flow stream. This leadership in high-end Mexican beer imports creates a significant competitive moat in the US market.
Bearish
- Recent Revenue Decline & Guidance Miss: Q3 FY2026 revenue declined 9.8% year-over-year to $2.22 billion, a significant deceleration. Recent news confirms the stock fell after Q4 earnings due to disappointing future profit guidance that missed Wall Street expectations.
- Severe Technical Downtrend & Underperformance: The stock is down 19.08% over the past year, severely underperforming the S&P 500's 27.88% gain. Trading at approximately 62% of its 52-week range, it shows persistent negative momentum and relative weakness.
- High Financial Leverage: The company carries a debt-to-equity ratio of 1.39, indicating a levered balance sheet. While manageable, this high debt load warrants monitoring in a rising interest rate environment and could pressure financial flexibility.
- Extreme Revenue Concentration Risk: Over 90% of revenue depends on the imported beer portfolio, creating significant vulnerability to any competitive, regulatory, or consumer preference shifts in this single category. The wine and spirits segment is a minimal contributor at $213 million last quarter.
STZ Technical Analysis
The stock is in a clear downtrend, having declined 19.08% over the past year, significantly underperforming the S&P 500, which gained 27.88% over the same period. With a current price of $149.50, STZ is trading at approximately 62% of its 52-week range, positioned closer to its 52-week low of $126.45 than its high of $186.40, suggesting the stock is in a phase of significant underperformance and potential oversold territory. Recent momentum is weak and confirms the longer-term downtrend, with the stock down 4.70% over the past month and 4.42% over the past three months, a period during which the broader market (SPY) posted gains of 4.84% and 8.15%, respectively, indicating severe negative relative strength. The stock's low beta of 0.424 signals it has been significantly less volatile than the market, yet its price action has been consistently negative, pointing to persistent, low-volatility selling pressure. Key technical support is firmly established at the 52-week low of $126.45, while resistance sits near the 52-week high of $186.40; a sustained breakdown below the $126.45 support could trigger a new leg down, whereas a recovery above the $165-$170 area would be needed to signal a potential trend reversal. The stock's beta of 0.424 indicates it is approximately 58% less volatile than the SPY, which is unusually defensive for a consumer staple but aligns with its recent price behavior of steady, grinding declines rather than sharp corrections.
Beta
0.42
0.42x market volatility
Max Drawdown
-34.8%
Largest decline past year
52-Week Range
$126-$186
Price range past year
Annual Return
-19.1%
Cumulative gain past year
| Period | STZ Return | S&P 500 |
|---|---|---|
| 1m | -4.7% | +4.4% |
| 3m | -4.4% | +8.5% |
| 6m | +11.9% | +9.7% |
| 1y | -19.1% | +28.8% |
| ytd | +5.9% | +9.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
STZ Fundamental Analysis
The company's revenue trajectory shows recent softness, with Q3 FY2026 revenue of $2.22 billion representing a 9.8% year-over-year decline, a significant deceleration from the strong growth in prior quarters; for instance, revenue grew 5.7% year-over-year in Q1 FY2026 to $2.51 billion. The beer segment, which generated $2.01 billion in the last quarter, remains the overwhelming driver, while the wine and spirits segment contributed only $213 million, highlighting the company's heavy dependence on its imported beer portfolio. Constellation remains solidly profitable, with Q3 net income of $502.8 million and a trailing net margin of 18.5%, though this profitability is down from the prior-year Q3 net income of $615.9 million. The company maintains robust gross margins, with a trailing gross margin of 51.55% and an operating margin of 31.33%, which are healthy for the beverage industry, but investors are scrutinizing the sustainability of these margins in the face of potential input cost pressures and competitive dynamics. The balance sheet is levered but manageable, with a debt-to-equity ratio of 1.39 and a current ratio of 1.08, indicating adequate short-term liquidity. The company generates strong cash flow, with trailing twelve-month free cash flow of $1.76 billion, providing ample capacity for its dividend (yield of 2.58%), share buybacks, and debt service, though the high debt load warrants monitoring in a rising interest rate environment.
Quarterly Revenue
$2.2B
2025-11
Revenue YoY Growth
-0.09%
YoY Comparison
Gross Margin
+0.53%
Latest Quarter
Free Cash Flow
$1.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is STZ Overvalued?
Given the company's consistent profitability, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E is 16.4x, while the forward P/E is 12.0x, indicating the market expects a significant earnings recovery, as the forward multiple implies a 27% discount to the trailing figure based on analyst EPS growth projections. Compared to the Consumer Defensive sector, STZ's trailing P/E of 16.4x is generally in line with large-cap beverage peers, though a precise industry average is not provided in the data; the stock does not appear to trade at a significant sector premium or discount based on this metric. Historically, the stock's own P/E ratio has fluctuated significantly, from a low around 11.96x in Q3 FY2026 to highs above 80x during periods of earnings volatility in early FY2024; the current trailing P/E of 16.4x sits near the middle of its recent historical range, suggesting the market is pricing in a stabilization of earnings but not an aggressive growth reacceleration, aligning with the cautious guidance recently provided by management.
PE
16.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -21x~6710x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are centered on revenue concentration and leverage. Over 90% of revenue comes from the beer segment, creating extreme vulnerability to any demand shift, competitive incursion, or regulatory change affecting Mexican beer imports. The balance sheet is levered with a debt-to-equity ratio of 1.39, and while strong free cash flow of $1.76 billion provides coverage, sustained earnings pressure could strain this position. Recent quarterly revenue declined 9.8% YoY, and net income fell from $615.9 million to $502.8 million year-over-year in Q3, highlighting earnings volatility and margin pressure risks.
Market & Competitive Risks include valuation stagnation and sector consolidation. The stock's trailing P/E of 16.4x is not excessive, but the forward P/E of 12.0x implies the market expects a recovery that may not materialize if growth stalls further. The low beta of 0.424 indicates defensive characteristics but has not prevented a 19% annual decline, suggesting stock-specific selling pressure. Recent industry news highlights a 'growth hangover' and defensive consolidation via large mergers, signaling a potentially tougher environment for organic growth and pricing power, which could compress multiples for the entire sector.
Worst-Case Scenario involves a perfect storm where slowing consumer demand for premium beer intensifies, input costs rise, and the company's heavy debt load becomes burdensome amid higher interest rates. This could lead to consecutive earnings misses, a dividend cut, and a loss of investor confidence in the growth story. The realistic downside is significant, referencing the 52-week low of $126.45, which is 15.4% below the current price of $149.50. A breach of that support could trigger a new leg down, with the maximum drawdown of -34.75% serving as a historical guide for potential losses in a severe adverse scenario.